Reorganization of Substance Use Treatment and Harm Reduction Services During the COVID-19 Pandemic: A Global Survey

dc.contributor.authorRadfar, Seyed Ramin
dc.contributor.authorDe Jong, Cornelis A. J.
dc.contributor.authorFarhoudian, Ali
dc.contributor.authorEbrahimi, Mohsen
dc.contributor.authorRafei, Parnian
dc.contributor.authorVahidi, Mehrnoosh
dc.contributor.authorYunesian, Masud
dc.contributor.authorKouimtsidis, Christos
dc.contributor.authorArunogiri, Shalini
dc.contributor.authorMassah, Omid
dc.contributor.authorDeylamizadeh, Abbas
dc.contributor.authorBrady, Kathleen T.
dc.contributor.authorBusse, Anja
dc.contributor.authorISAM-PPIG Global Survey Consortium
dc.contributor.authorPotenza, Marc N.
dc.contributor.authorEkhtiari, Hamed
dc.contributor.authorBaldacchino, Alexander Mario
dc.contributor.departmentPsychiatry, School of Medicine
dc.date.accessioned2024-10-24T14:19:57Z
dc.date.available2024-10-24T14:19:57Z
dc.date.issued2021-04-29
dc.description.abstractBackground: The coronavirus disease 2019 (COVID-19) pandemic has impacted people with substance use disorders (SUDs) worldwide, and healthcare systems have reorganized their services in response to the pandemic. Methods: One week after the announcement of the COVID-19 as a pandemic, in a global survey, 177 addiction medicine professionals described COVID-19-related health responses in their own 77 countries in terms of SUD treatment and harm reduction services. The health responses were categorized around (1) managerial measures and systems, (2) logistics, (3) service providers, and (4) vulnerable groups. Results: Respondents from over 88% of countries reported that core medical and psychiatric care for SUDs had continued; however, only 56% of countries reported having had any business continuity plan, and 37.5% of countries reported shortages of methadone or buprenorphine supplies. Participants of 41% of countries reported partial discontinuation of harm-reduction services such as needle and syringe programs and condom distribution. Fifty-seven percent of overdose prevention interventions and 81% of outreach services were also negatively impacted. Conclusions: Participants reported that SUD treatment and harm-reduction services had been significantly impacted globally early during the COVID-19 pandemic. Based on our findings, we highlight several issues and complications resulting from the pandemic concerning people with SUDs that should be tackled more efficiently during the future waves or similar pandemics. The issues and potential strategies comprise the following: (1) helping policymakers to generate business continuity plans, (2) maintaining the use of evidence-based interventions for people with SUDs, (3) being prepared for adequate medication supplies, (4) integrating harm reduction programs with other treatment modalities, and (5) having specific considerations for vulnerable groups such as immigrants and refugees.
dc.eprint.versionFinal published version
dc.identifier.citationRadfar SR, De Jong CAJ, Farhoudian A, et al. Reorganization of Substance Use Treatment and Harm Reduction Services During the COVID-19 Pandemic: A Global Survey. Front Psychiatry. 2021;12:639393. Published 2021 Apr 29. doi:10.3389/fpsyt.2021.639393
dc.identifier.urihttps://hdl.handle.net/1805/44209
dc.language.isoen_US
dc.publisherFrontiers Media
dc.relation.isversionof10.3389/fpsyt.2021.639393
dc.relation.journalFrontiers in Psychiatry
dc.rightsAttribution 4.0 Internationalen
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.sourcePMC
dc.subjectCOVID-19 pandemic
dc.subjectSubstance use disorder
dc.subjectPublic health
dc.subjectDrug policy
dc.subjectOpioid agonist treatment
dc.subjectAddiction services
dc.subjectHarm reduction
dc.titleReorganization of Substance Use Treatment and Harm Reduction Services During the COVID-19 Pandemic: A Global Survey
dc.typeArticle
Files
Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Radfar2021Reorganization-CCBY.pdf
Size:
3.66 MB
Format:
Adobe Portable Document Format
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
2.04 KB
Format:
Item-specific license agreed upon to submission
Description: